Artículos por temáticas

Clinical improvement and cortical adaptations after functional electrical stimulation in Parkinson's disease patients.

Popa L, Constantinescu A, Mureşanu DF, Irimie A, Bălănescu NR, Popescu CD.

CNS Neurol Disord Drug Targets. 2013 Mar;12(2):265-73.

Cognitive profiles of patients with mild cognitive impairment or dementia in Alzheimer's or Parkinson's disease.

Hildebrandt H, Fink F, Kastrup A, Haupts M, Eling P.

Dement Geriatr Cogn Dis Extra. 2013 Apr 3;3(1):102-12. doi: 10.1159/000348350.

A systematic review of biomarkers for disease progression in Parkinson's disease.

McGhee DJ, Royle PL, Thompson PA, Wright DE, Zajicek JP, Counsell CE.

BMC Neurol. 2013 Apr 12;13:35. doi: 10.1186/1471-2377-13-35. Review.

Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study.

Zhu K, van Hilten JJ, Putter H, Marinus J.

Mov Disord. 2013 Jun;28(6):755-62. doi: 10.1002/mds.25389.

Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.

Mahlknecht P, Seppi K, Stockner H, Nocker M, Scherfler C, Kiechl S, Willeit J, Schmidauer C, Gasperi A, Rungger G, Poewe W.

Neurodegener Dis. 2013;12(4):212-8. doi: 10.1159/000348595.

[Influence of electroacupuncture on p38-mitogen activated protein kinase in substantia nigra cells of rats with Parkinson disease model].

Wang SJ, Fang JQ, Ma J, Wang YC, Zeng XL, Zhou D, Sun GJ.

Zhongguo Zhen Jiu. 2013 Apr;33(4):329-33. Chinese.

Management of upper extremity dysfunction in people with Parkinson disease and Huntington disease: facilitating outcomes across the disease lifespan.

Quinn L, Busse M, Dal Bello-Haas V.

J Hand Ther. 2013 Apr-Jun;26(2):148-54; quiz 155. doi: 10.1016/j.jht.2012.11.001. Review.

Moving from physician-centered care towards patient-centered care for Parkinson's disease patients.

van der Eijk M, Nijhuis FA, Faber MJ, Bloem BR.

Parkinsonism Relat Disord. 2013 Nov;19(11):923-7. doi: 10.1016/j.parkreldis.2013.04.022. Review.

Training effects of a 12-week walking program on Parkinson disease patients and community-dwelling older adults.

Cheng SP, Yang CY, Tang FI, Chen IJ.

NeuroRehabilitation. 2013;32(4):967-76. doi: 10.3233/NRE-130920.

Preliminary results of ON/OFF detection using an integrated system for Parkinson's disease monitoring.

Pastorino M, Cancela J, Arredondo MT, Pastor-Sanz L, Contardi S, Valzania F.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:941-4. doi: 10.1109/EMBC.2013.6609657.

RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis.

Heman-Ackah SM, Hallegger M, Rao MS, Wood MJ.

Front Mol Neurosci. 2013 Nov 20;6:40. doi: 10.3389/fnmol.2013.00040. Review.

Very long-standing Parkinson's disease.

Garcia-Ruiz PJ, del Val J, Herranz A.

Eur Neurol. 2013;70(3-4):172-4. doi: 10.1159/000351774. No abstract available.

Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk.

Moskvina V, Harold D, Russo G, Vedernikov A, Sharma M, Saad M, Holmans P, Bras JM, Bettella F, Keller MF, Nicolaou N, Simón-Sánchez J, Gibbs JR, Schulte C, Durr A, Guerreiro R, Hernandez D, Brice A, S

JAMA Neurol. 2013 Oct;70(10):1268-76.

[Efficacy and safety of ropinirole in the treatment of Parkinson's disease: a multi-center, randomized, double-blind and bromocriptine-controlled trial].

Li SH, Chen HB, Wang ZF, Tang RH, Zhang XY, Yang JS, Zhao WQ, Sun XR, Ma J.

Zhonghua Yi Xue Za Zhi. 2013 Jul 2;93(25):1952-7. Chinese.

Ambiguous idiom processing in Parkinson's disease patients.

Papagno C, Mattavelli G, Cattaneo Z, Romito L, Albanese A.

Cogn Neuropsychol. 2013;30(7-8):495-506. doi: 10.1080/02643294.2013.876397.